Home/Filings/4/0001495384-20-000002
4//SEC Filing

Venrock Associates VI, L.P. 4

Accession 0001495384-20-000002

CIK 0001770787other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 4:09 PM ET

Size

14.7 KB

Accession

0001495384-20-000002

Insider Transaction Report

Form 4
Period: 2020-05-20
Transactions
  • Conversion

    Class A Common Stock

    2020-05-20+1,013,5692,301,394 total(indirect: By Funds)
  • Sale

    Class A Common Stock

    2020-05-20$78.00/sh1,013,569$79,058,3821,287,825 total(indirect: By Funds)
  • Conversion

    Class B Common Stock

    2020-05-201,013,5698,790,422 total(indirect: By Funds)
    Class A Common Stock (1,013,569 underlying)
Transactions
  • Conversion

    Class A Common Stock

    2020-05-20+1,013,5692,301,394 total(indirect: By Funds)
  • Sale

    Class A Common Stock

    2020-05-20$78.00/sh1,013,569$79,058,3821,287,825 total(indirect: By Funds)
  • Conversion

    Class B Common Stock

    2020-05-201,013,5698,790,422 total(indirect: By Funds)
    Class A Common Stock (1,013,569 underlying)
Transactions
  • Sale

    Class A Common Stock

    2020-05-20$78.00/sh1,013,569$79,058,3821,287,825 total(indirect: By Funds)
  • Conversion

    Class B Common Stock

    2020-05-201,013,5698,790,422 total(indirect: By Funds)
    Class A Common Stock (1,013,569 underlying)
  • Conversion

    Class A Common Stock

    2020-05-20+1,013,5692,301,394 total(indirect: By Funds)
Transactions
  • Sale

    Class A Common Stock

    2020-05-20$78.00/sh1,013,569$79,058,3821,287,825 total(indirect: By Funds)
  • Conversion

    Class A Common Stock

    2020-05-20+1,013,5692,301,394 total(indirect: By Funds)
  • Conversion

    Class B Common Stock

    2020-05-201,013,5698,790,422 total(indirect: By Funds)
    Class A Common Stock (1,013,569 underlying)
Footnotes (4)
  • [F1]Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation.
  • [F2]Represents (a) 8,150,480 shares of Class B common stock held by Venrock Associates VI, L.P. ("VA VI") and (b) 639,942 shares of Class B common stock held by Venrock Partners VI, L.P. ("VP VI"). Venrock Management VI, LLC ("VM VI") is the sole general partner of VA VI. Venrock Partners Management VI, LLC ("VPM VI") is the sole general partner of VP VI. VM VI and VPM VI disclaim beneficial ownership over all shares held by VA VI and VP VI, respectively, except to the extent of their indirect pecuniary interests therein.
  • [F3]Represents (a) 2,133,852 shares of Class A common stock held by VA VI and (b) 167,542 shares of Class A common stock held by VP VI. VM VI is the sole general partner of VA VI. VPM VI is the sole general partner of VP VI. VM VI and VPM VI disclaim beneficial ownership over all shares held by VA VI and VP VI, respectively, except to the extent of their indirect pecuniary interests therein.
  • [F4]Represents (a) 1,194,071 shares of Class A common stock held by VA VI and (b) 93,754 shares of Class A common stock held by VP VI. VM VI is the sole general partner of VA VI. VPM VI is the sole general partner of VP VI. VM VI and VPM VI disclaim beneficial ownership over all shares held by VA VI and VP VI, respectively, except to the extent of their indirect pecuniary interests therein.

Issuer

10x Genomics, Inc.

CIK 0001770787

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001495384

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:09 PM ET
Size
14.7 KB